within Pharmacolibrary.Drugs.ATC.N;

model N06AA16
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 20 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 75 / 1000000,
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0028333333333333335,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dosulepin (also known as dothiepin) is a tricyclic antidepressant (TCA) used primarily for the treatment of major depressive disorder and sometimes certain forms of anxiety and neuropathic pain. Once widely prescribed in the UK and some other countries, its use is now much less common due to concerns over safety in overdose. It has limited current approval; in some jurisdictions, its use is being phased out.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult population based on secondary sources, as no direct referenced population PK models are available in published literature.</p><h4>References</h4><ol><li><p>Lancaster, SG, &amp; Gonzalez, JP (1989). Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. <i>Drugs</i> 38(1) 123–147. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198938010-00005&quot;>10.2165/00003495-198938010-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2670509/&quot;>https://pubmed.ncbi.nlm.nih.gov/2670509</a></p></li><li><p>Maguire, KP, et al., &amp; Scoggins, BA (1981). Metabolism and pharmacokinetics of dothiepin. <i>British journal of clinical pharmacology</i> 12(3) 405–409. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1981.tb01235.x&quot;>10.1111/j.1365-2125.1981.tb01235.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7295471/&quot;>https://pubmed.ncbi.nlm.nih.gov/7295471</a></p></li><li><p>Ogura, C, et al., &amp; Kawahara, K (1983). Age differences in effects on blood pressure, flicker fusion frequency, salivation and pharmacokinetics of single oral doses of dothiepin and amitriptyline. <i>European journal of clinical pharmacology</i> 25(6) 811–814. DOI:<a href=&quot;https://doi.org/10.1007/BF00542525&quot;>10.1007/BF00542525</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6662179/&quot;>https://pubmed.ncbi.nlm.nih.gov/6662179</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N06AA16;
